Regenerative medicine developer Elanix Biotechnologies said today it has raised $9.1 million (EU €7.8 million) with the opportunity to raise an additional $2.6 million (EU €2.1 million) through a private placement. The Germany-based company said that funds in the round are slated to support expanding its product portfolio, distribution and sales network and an e-commerce […]
Regenerative Medicine
A next-gen EEG could help restore lost brain function
Researchers are developing a device that combines electrical brain stimulation with EEG recording, opening potential new paths for treating neurological disorders. The device, under development at the U.S. Department of Energy’s SLAC National Accelerator Laboratory and Stanford University, could help bring back lost brain function by measuring how the brain responds to therapies that stimulate […]
Bone Biologics raises another $6m
Bone Biologics (OTC:BBLG) said today that it raised another $5.9 million for the orthobiologics it makes for spinal fusion procedures. The round includes $3.9 million in equity and a $2 million credit facility, the Burlington, Mass.-based company said. Bone Biologics said it plans to use the proceeds for working capital, protein development and regulatory and clinical […]
Bioventus to deal Pfizer bone protein program to PE shop
Bioventus said today that it agreed to sell the bone morphogenetic protein technology it licensed from Pfizer (NYSE:PFE) to private equity shop that specializes in the orthopedics industry for an undisclosed amount. Created in a 2012 spinout worth $367 million from Smith & Nephew (FTSE:SN, NYSE:SNN), Bioventus in 2013 inked a deal with Pfizer to develop a next-generation BMP product. In October 2014 […]
Sanuwave Health, HyperMed partner for DermaPace diabetic foot ulcer study
Sanuwave Health (OTC:SNWV) said yesterday it is partnering with HyperMed to sponsor a clinical investigation exploring Sanuwave’s DermaPace system designed for treating diabetic foot ulcers. The joint study will look to quantify the level of increased perfusion and oxygenation during and after treatment with the DermaPace, Suwanee, Ga.-based Sanuwave said. The study will use HyperMed’s Hyperview […]
CollPlant wins Israeli grant for BioInk 3D printed organs
Regenerative medicine company CollPlant said today it received agrant from the Israel Innovation Authority to help support its plant-based rhCollagen technology for tissue repairs. The grant will specifically support uses of its rhCollagen-based formulations intended for use as BioInk for 3D printing tissues and organs, the company said. The total budget for the program $1.2 million (NIS […]
Avita Medical touts publication of pivotal ReCell trial data
Avita Medical (ASX:AVH) today released results from a pivotal clinical trial of its ReCell autologous cell harvesting device in treating deep partial-thickness second-degree burns. The ReCell autologous cell harvesting device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, reconstructive and cosmetic procedures, Avita said. Results from […]
InVivo Therapeutics prices $13m offering
InVivo Therapeutics (NSDQ:NVIV) today priced a public stock offering worth more than $13 million for the neurospinal scaffold it’s developing to treat spinal cord injuries. Cambridge, Mass.-based InVivo said it plans to float some 388,000 shares and another 388,000 warrants at a combined price of $2 per unit, plus 6.2 million pre-funded warrants and 6.2 million […]
PolarityTE aims to ‘wage war on skin grafts’ with regenerative tech
PolarityTE wants to eliminate skin grafts with its platform of regenerative technology. The Utah-based biotech is still new to the industry, but co-founders Denver Lough and Ned Swanson are betting that their company can take on the clinical standard of care for wound management. “No other product, whether it be a drug, a biologic device, or […]
Osiris levels $7m trade theft, breach-of-contract suit against MiMedx over Stability Biologics deal
Osiris Therapeutics leveled trade theft and breach-of-contract charges worth nearly $7 million against a regenerative medicine rival, stemming from the Stability Biologics acquisition by MiMedx (NSDQ:MDXG). Columbia, Md.-based Osiris said it inked a distribution deal back in 2013 to have Stability sell a pair of its products through the end of 2015. But after MiMedx paid $10 million for […]
DARPA is developing a human memory prosthesis: Here’s how
The Defense Advanced Research Projects Agency (DARPA) has successfully created what it is calling a human memory prosthesis, a system with electrodes implanted in the brain that restores memory function using a person’s own neural codes. DARPA has been working on restoring normal memory function in military personnel since 2013 in a program known as […]